Center for Scientific Review; Notice of Closed Meetings, 72858-72859 [2024-20096]
Download as PDF
<![CDATA[
72858
Federal Register / Vol. 89, No. 173 / Friday, September 6, 2024 / Notices
identify the guidance you are
requesting.
III. Paperwork Reduction Act of 1995
While this guidance contains no new
collection of information, it does refer to
previously approved FDA collections of
information. The previously approved
collections of information are subject to
review by the Office of Management and
Budget (OMB) under the Paperwork
21 CFR part; guidance; or FDA form
Topic
807, subpart E .........................................................................
814, subparts A through E ......................................................
814, subpart H .........................................................................
812 ...........................................................................................
860, subpart D .........................................................................
‘‘Requests for Feedback and Meetings for Medical Device
Submissions: The Q-Submission Program’’.
800, 801, 809, and 830 ...........................................................
Premarket notification ..............................................................
Premarket approval .................................................................
Humanitarian Use Devices; Humanitarian Device Exemption
Investigational Device Exemption ...........................................
De Novo classification process ...............................................
Q-submissions and Early Payor Feedback Request Programs for Medical Devices.
Medical Device Labeling Regulations; Unique Device Identification.
Protection of Human Subjects and Institutional Review
Boards.
50, 56 .......................................................................................
[FR Doc. 2024–20069 Filed 9–5–24; 8:45 am]
Dated: August 30, 2024.
Miguelina Perez,
Program Analyst, Office of Federal Advisory
Committee Policy.
BILLING CODE 4164–01–P
[FR Doc. 2024–20094 Filed 9–5–24; 8:45 am]
Dated: August 30, 2024.
Lauren K. Roth,
Associate Commissioner for Policy.
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Institutes of Health
National Institute on Aging; Notice of
Closed Meeting
Pursuant to section 1009 of the
Federal Advisory Committee Act, as
amended, notice is hereby given of the
following meeting.
The meeting will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
lotter on DSK11XQN23PROD with NOTICES1
Reduction Act of 1995 (PRA) (44 U.S.C.
3501–3521). The collections of
information in the following table have
been approved by OMB:
Name of Committee: National Institute on
Aging Special Emphasis Panel; NSC BBA.
Date: October 10, 2024.
Time: 9:30 a.m. to 5:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institute on Aging, 5601
Fishers Lane, Rockville, MD 20892 (Virtual
Meeting).
Contact Person: Bita Nakhai, Ph.D.,
Scientific Review Officer, National Institute
of Aging, National Institute of Health, 5601
Fishers Lane, 2C212, Rockville, MD 20852,
301–402–7701, nakhaib@nia.nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.866, Aging Research,
National Institutes of Health, HHS)
VerDate Sep<11>2014
16:42 Sep 05, 2024
Jkt 262001
Center for Scientific Review; Notice of
Closed Meetings
Pursuant to section 1009 of the
Federal Advisory Committee Act, as
amended, notice is hereby given of the
following meetings.
The meetings will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: Molecular, Cellular
and Developmental Neuroscience Integrated
Review Group; Neurogenesis and Cell Fate
Study Section.
Date: October 2, 2024.
Time: 9:00 a.m. to 7:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health,
Rockledge II, 6701 Rockledge Drive,
Bethesda, MD 20892 (Virtual Meeting).
Contact Person: Adem Can, Ph.D.,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 4190,
MSC 7850, Bethesda, MD 20892, (301) 435–
1042, cana2@csr.nih.gov.
PO 00000
Frm 00039
Fmt 4703
Sfmt 4703
OMB control No.
0910–0120
0910–0231
0910–0332
0910–0078
0910–0844
0910–0756
0910–0485
0910–0130
Name of Committee: Brain Disorders and
Clinical Neuroscience Integrated Review
Group; Pathophysiology of Eye Disease—1
Study Section Pathophysiology of Eye
Disease—1 Study Section (PED1).
Date: October 7–8, 2024.
Time: 9:00 a.m. to 7:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: Residence Inn Bethesda, 7335
Wisconsin Avenue, Bethesda, MD 20814 (InPerson Meeting).
Contact Person: Afia Sultana, Ph.D.,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 4189,
Bethesda, MD 20892, (301) 827–7083,
sultanaa@mail.nih.gov.
Name of Committee: Biobehavioral and
Behavioral Processes Integrated Review
Group; Child Psychopathology and
Developmental Disabilities Study Section.
Date: October 7–8, 2024.
Time: 9:00 a.m. to 8:30 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health,
Rockledge II, 6701 Rockledge Drive,
Bethesda, MD 20892 (Virtual Meeting).
Contact Person: Michael L. Bloom, Ph.D.,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 6187,
MSC 7804, Bethesda, MD 20892, 301–451–
0132, bloomm2@mail.nih.gov.
Name of Committee: Center for Scientific
Review Special Emphasis Panel; ECHO IDeA
States Pediatric Clinical Trials Networks.
Date: October 7–8, 2024.
Time: 3:00 p.m. to 5:30 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health,
Rockledge II, 6701 Rockledge Drive,
Bethesda, MD 20892 (Virtual Meeting).
Contact Person: Andrew M. Wolfe, Ph.D.,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Dr., Room 6214,
Bethesda, MD 20892, andrew.wolfe@nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.306, Comparative Medicine;
93.333, Clinical Research, 93.306, 93.333,
E:\FR\FM\06SEN1.SGM
06SEN1
Federal Register / Vol. 89, No. 173 / Friday, September 6, 2024 / Notices
93.337, 93.393–93.396, 93.837–93.844,
93.846–93.878, 93.892, 93.893, National
Institutes of Health, HHS)
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Dated: September 3, 2024.
Miguelina Perez,
Program Analyst, Office of Federal Advisory
Committee Policy.
National Institutes of Health
[FR Doc. 2024–20096 Filed 9–5–24; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Institute of Allergy and
Infectious Diseases; Notice of Closed
Meeting
lotter on DSK11XQN23PROD with NOTICES1
Pursuant to section 1009 of the
Federal Advisory Committee Act, as
amended, notice is hereby given of the
following meeting.
The meeting will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Institute of
Allergy and Infectious Diseases Special
Emphasis Panel; NIAID Investigator Initiated
Program Project Applications (P01 Clinical
Trial Not Allowed).
Date: October 15, 2024.
Time: 9:00 a.m. to 12:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institute of Allergy and
Infectious Diseases, National Institutes of
Health, 5601 Fishers Lane, Room 3G31A,
Rockville, MD 20892 (Video Assisted
Meeting).
Contact Person: Mairi Noverr, Ph.D.,
Scientific Review Officer, National Institute
of Allergy and Infectious Diseases, National
Institutes of Health, 5601 Fishers Lane, Room
3G31A, Rockville, MD 20892, (240) 747–
7530, mairi.noverr@nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.855, Allergy, Immunology,
and Transplantation Research; 93.856,
Microbiology and Infectious Diseases
Research, National Institutes of Health, HHS)
Dated: September 3, 2024.
Lauren A. Fleck,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2024–20125 Filed 9–5–24; 8:45 am]
BILLING CODE 4140–01–P
VerDate Sep<11>2014
16:42 Sep 05, 2024
Jkt 262001
National Institute of Arthritis and
Musculoskeletal and Skin Diseases;
Notice of Closed Meetings
Pursuant to section 1009 of the
Federal Advisory Committee Act, as
amended, notice is hereby given of the
following meetings.
The meetings will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Institute of
Arthritis and Musculoskeletal and Skin
Diseases Special Emphasis Panel: NIAMS
AMS/AMSC Member Conflict Review.
Date: October 22, 2024.
Time: 2:00 p.m. to 5:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institute of Arthritis and
Musculoskeletal and Skin Diseases, 6701
Democracy Boulevard, Bethesda, MD 20892
(Virtual Meeting).
Contact Person: Chiguang Feng, Ph.D.,
Scientific Review Officer, Scientific Review
Branch, National Institute of Arthritis and
Musculoskeletal and Skin Diseases, 6701
Democracy Boulevard, Room 808, Bethesda,
MD 20892, (301) 451–7766, chiguang.feng@
nih.gov.
Name of Committee: National Institute of
Arthritis and Musculoskeletal and Skin
Diseases Special Emphasis Panel: NIAMS
P50 Wellstone Review.
Date: October 29–30, 2024.
Time: 10:00 a.m. to 5:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institute of Arthritis and
Musculoskeletal and Skin Diseases, 6701
Democracy Boulevard, Bethesda, MD 20892
(Virtual Meeting).
Contact Person: Kan Ma, Ph.D., Scientific
Review Officer, Scientific Review Branch,
National Institute of Arthritis,
Musculoskeletal and Skin Diseases, NIH 6701
Democracy Boulevard, Suite 814, Bethesda,
MD 20892, (301) 451–4838, mak2@
mail.nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.846, Arthritis,
Musculoskeletal and Skin Diseases Research,
National Institutes of Health, HHS)
PO 00000
Frm 00040
Fmt 4703
Sfmt 4703
72859
Dated: August 30, 2024.
Miguelina Perez,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2024–20098 Filed 9–5–24; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Institute on Aging; Notice of
Closed Meeting
Pursuant to section 1009 of the
Federal Advisory Committee Act, as
amended, notice is hereby given of the
following meeting.
The meeting will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Institute on
Aging Special Emphasis Panel;
Neuroplasticity in Auditory Aging and
Cognitive Impairment.
Date: October 9, 2024.
Time: 11:30 a.m. to 5:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institute on Aging, 5601
Fishers Ln., Rockville, MD 20852 (Virtual
Meeting).
Contact Person: Nesar Uddin Akanda,
M.D., Ph.D., Scientific Review Officer,
National Institute of Aging, National Institute
of Health, 7201 Wisconsin Ave., Rm 2E405,
Bethesda, MD 20892, (301) 594–8984,
nesar.akanda@nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.866, Aging Research,
National Institutes of Health, HHS)
Dated: August 30, 2024.
Miguelina Perez,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2024–20093 Filed 9–5–24; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Institute on Aging; Notice of
Closed Meeting
Pursuant to section 1009 of the
Federal Advisory Committee Act, as
E:\FR\FM\06SEN1.SGM
06SEN1
]]>Agencies
[Federal Register Volume 89, Number 173 (Friday, September 6, 2024)]
[Notices]
[Pages 72858-72859]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2024-20096]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health
Center for Scientific Review; Notice of Closed Meetings
Pursuant to section 1009 of the Federal Advisory Committee Act, as
amended, notice is hereby given of the following meetings.
The meetings will be closed to the public in accordance with the
provisions set forth in sections 552b(c)(4) and 552b(c)(6), title 5
U.S.C., as amended. The grant applications and the discussions could
disclose confidential trade secrets or commercial property such as
patentable material, and personal information concerning individuals
associated with the grant applications, the disclosure of which would
constitute a clearly unwarranted invasion of personal privacy.
Name of Committee: Molecular, Cellular and Developmental
Neuroscience Integrated Review Group; Neurogenesis and Cell Fate
Study Section.
Date: October 2, 2024.
Time: 9:00 a.m. to 7:00 p.m.
Agenda: To review and evaluate grant applications.
Place: National Institutes of Health, Rockledge II, 6701
Rockledge Drive, Bethesda, MD 20892 (Virtual Meeting).
Contact Person: Adem Can, Ph.D., Scientific Review Officer,
Center for Scientific Review, National Institutes of Health, 6701
Rockledge Drive, Room 4190, MSC 7850, Bethesda, MD 20892, (301) 435-
1042, [email protected].
Name of Committee: Brain Disorders and Clinical Neuroscience
Integrated Review Group; Pathophysiology of Eye Disease--1 Study
Section Pathophysiology of Eye Disease--1 Study Section (PED1).
Date: October 7-8, 2024.
Time: 9:00 a.m. to 7:00 p.m.
Agenda: To review and evaluate grant applications.
Place: Residence Inn Bethesda, 7335 Wisconsin Avenue, Bethesda,
MD 20814 (In-Person Meeting).
Contact Person: Afia Sultana, Ph.D., Scientific Review Officer,
Center for Scientific Review, National Institutes of Health, 6701
Rockledge Drive, Room 4189, Bethesda, MD 20892, (301) 827-7083,
[email protected].
Name of Committee: Biobehavioral and Behavioral Processes
Integrated Review Group; Child Psychopathology and Developmental
Disabilities Study Section.
Date: October 7-8, 2024.
Time: 9:00 a.m. to 8:30 p.m.
Agenda: To review and evaluate grant applications.
Place: National Institutes of Health, Rockledge II, 6701
Rockledge Drive, Bethesda, MD 20892 (Virtual Meeting).
Contact Person: Michael L. Bloom, Ph.D., Scientific Review
Officer, Center for Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 6187, MSC 7804, Bethesda, MD
20892, 301-451-0132, [email protected].
Name of Committee: Center for Scientific Review Special Emphasis
Panel; ECHO IDeA States Pediatric Clinical Trials Networks.
Date: October 7-8, 2024.
Time: 3:00 p.m. to 5:30 p.m.
Agenda: To review and evaluate grant applications.
Place: National Institutes of Health, Rockledge II, 6701
Rockledge Drive, Bethesda, MD 20892 (Virtual Meeting).
Contact Person: Andrew M. Wolfe, Ph.D., Scientific Review
Officer, Center for Scientific Review, National Institutes of
Health, 6701 Rockledge Dr., Room 6214, Bethesda, MD 20892,
[email protected].
(Catalogue of Federal Domestic Assistance Program Nos. 93.306,
Comparative Medicine; 93.333, Clinical Research, 93.306, 93.333,
[[Page 72859]]
93.337, 93.393-93.396, 93.837-93.844, 93.846-93.878, 93.892, 93.893,
National Institutes of Health, HHS)
Dated: September 3, 2024.
Miguelina Perez,
Program Analyst, Office of Federal Advisory Committee Policy.
[FR Doc. 2024-20096 Filed 9-5-24; 8:45 am]
BILLING CODE 4140-01-P
